title: [Advantages of volume perfusion CT for evaluating the response of solid tumors to treatment with sunitinib].
authors.forename: M
authors.initials: M
authors.lastname: Horger
authors.forename: B
authors.initials: B
authors.lastname: Wiesinger
authors.forename: H G
authors.initials: HG
authors.lastname: Kopp
authors.forename: S D
authors.initials: SD
authors.lastname: Ioanoviciu
authors.forename: M
authors.initials: M
authors.lastname: Bitzer
authors.forename: D
authors.initials: D
authors.lastname: Spira
authors.forename: M
authors.initials: M
authors.lastname: Schulze
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods*; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D055420:Perfusion Imaging / Q000379:methods*; D011379:Prognosis; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome; D047368:Tumor Burden
chemical_list: D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib